Clinical Trial Update: A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for Anti-N-methyl-D-aspartate receptor encephalitis and anti-NMDA receptor antibody-associated psychiatric disease; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-n-methyl-d-aspartate Receptor Antibody-associated Psychiatric Disease
• Anti-n-methyl-d-aspartate Receptor Encephalitis
• Autoimmune Encephalitis

Snippet

Sponsor: Arialys Australia Pty Ltd | Conditions: Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease | Phase 2 | Status: NOT_YET_RECRUITING